Gland Pharma is open to explore strategic M&As to access new technologies, diversify portfolio
Earlier, the U.S. President had announced plans to impose a 25% tariff on India, along with an additional penalty, citing concerns over the country's energy and defence ties with Russia, as well as existing trade barriers
Get over your FOMO of knowing what's happening. Never miss what matters to you!